Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2017 (2017), Article ID 5797041, 4 pages
https://doi.org/10.1155/2017/5797041
Case Report

Antiphospholipid Syndrome: Multiple Manifestations in a Single Patient—A High Suspicion Is Still Needed

Department of Hematology/Oncology, Staten Island University Hospital, 475 Seaview Avenue, Staten Island, NY 10305, USA

Correspondence should be addressed to Uroosa Ibrahim; moc.liamg@miharbiasooru

Received 1 February 2017; Revised 12 April 2017; Accepted 4 May 2017; Published 23 May 2017

Academic Editor: Marco Sebastiani

Copyright © 2017 Uroosa Ibrahim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Lim, “Antiphospholipid syndrome,” Hematology, vol. 2013, no. 1, pp. 675–680, 2013. View at Publisher · View at Google Scholar
  2. S. Miyakis, M. D. Lockshin, T. Atsumi et al., “International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS),” Journal of Thrombosis and Haemostasis, vol. 4, no. 2, pp. 295–306, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Ruiz-Irastorza, M. Crowther, W. Branch, and M. A. Khamashta, “Antiphospholipid syndrome,” The Lancet, vol. 376, no. 9751, pp. 1498–1509, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Cervera, J. C. Piette, J. Font et al., “Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients,” Arthritis and Rheumatology, vol. 46, no. 6, pp. 1019–1027, 2002. View at Publisher · View at Google Scholar
  5. J. S. Levine, W. Branch, and J. Rauch, “The antiphospholipid syndrome,” New England Journal of Medicine, vol. 346, no. 10, pp. 752–763, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Francès, S. Niang, E. Laffitte, F. Le Pelletier, N. Costedoat, and J. C. Piette, “Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases,” Arthritis and Rheumatism, vol. 52, no. 6, pp. 1785–1793, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Artim-Esen, R. Diz-Küçükkaya, and M. İnanç, “The significance and management of thrombocytopenia in antiphospholipid syndrome,” Current Rheumatology Reports, vol. 17, article 14, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Paydas, R. Koçak, S. Zorludemir, and F. Baslamisli, “Bone marrow necrosis in antiphospholipid syndrome,” Journal of Clinical Pathology, vol. 50, no. 3, pp. 261-262, 1997. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Alarcón-Segovia, M. Delezé, C. V. Oria et al., “Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus a prospective analysis of 500 consecutive patients,” Medicine, vol. 68, no. 6, pp. 353–365, 1989. View at Publisher · View at Google Scholar
  10. R. A. Asherson, M. A. Khamashta, J. Ordi-Ros et al., “The ‘primary’ antiphospholipid syndrome,” Medicine, vol. 68, no. 6, pp. 366–374, 1989. View at Publisher · View at Google Scholar
  11. R. Levy, E. Avvad, J. Oliveira, and L. Porto, “Placental pathology in antiphospholipid syndrome,” Lupus, vol. 7, supplement 2, pp. S81–S85, 1998. View at Publisher · View at Google Scholar
  12. F. J. Muñoz-Rodríguez, J. Font, R. Cervera et al., “Clinical study and follow-up of 100 patients with the antiphospholipid syndrome,” Seminars in Arthritis and Rheumatism, vol. 29, no. 3, pp. 182–190, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Petri, M. Golbus, R. Anderson, Q. Whiting‐O'Keefe, L. Corash, and D. Hellmann, “Antinuclear antibody, lupus anticoagulant, and anticardiolipin antibody in women with idiopathic habitual abortion. A controlled, prospective study of forty‐four women,” Arthritis & Rheumatism, vol. 30, no. 6, pp. 601–606, 1987. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Avcin, “Primary antiphospholipid syndrome,” Current Opinion in Rheumatology, vol. 20, pp. 595–600, 2008. View at Google Scholar
  15. S. John, S. Manda, and D. Hamrock, “Cocaine-induced thrombotic vasculopathy,” American Journal of the Medical Sciences, vol. 342, no. 6, pp. 524–526, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. S. D. Treadwell and T. G. Robinson, “Cocaine use and stroke,” Postgraduate Medical Journal, vol. 83, no. 980, pp. 389–394, 2007. View at Publisher · View at Google Scholar
  17. S. Gulati and A. A. Donato, “Lupus anticoagulant and ANCA associated thrombotic vasculopathy due to cocaine contaminated with levamisole: a case report and review of the literature,” Journal of Thrombosis and Thrombolysis, vol. 34, no. 1, pp. 7–10, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Raddino, C. Pedrinazzi, G. Zanini, R. Procopio, and L. Dei Cas, “Acute myocardial infarction in a young woman with antiphospholipid syndrome and occasional cocaine abuse,” International Journal of Cardiology, vol. 105, no. 2, pp. 236–238, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Alarcón-Segovia, M. C. Boffa, W. Branch et al., “Prophylaxis of the antiphospholipid syndrome: a consensus report,” Lupus, vol. 12, no. 7, pp. 499–503, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Ruiz-Irastorza, M. J. Cuadrado, I. Ruiz-Arruza et al., “Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on Antiphospholipid Antibodies,” Lupus, vol. 20, no. 2, pp. 206–218, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Negrini, F. Pappalardo, G. Murdaca, F. Indiveri, and F. Puppo, “The antiphospholipid syndrome: from pathophysiology to treatment,” Clinical and Experimental Medicine, pp. 1–11, 2016. View at Publisher · View at Google Scholar · View at Scopus